Irenic Issues Presentation Detailing Multiple Pathways to Reverse Underperformance and Accelerate Value Creation at Workiva — Neutral
WK Business Wire — September 29, 2025NEW YORK--(BUSINESS WIRE)--Irenic Capital Management, LP, a significant shareholder of Workiva, Inc. (“Workiva” or the “Company”) (NYSE: WK) with approximately 2% of the Company's outstanding shares, today issued a presentation outlining actionable recommendations to address the Company's significant share price underperformance relative to peers and create value for all shareholders. Irenic issued the following statement: “Workiva is a high-quality business with market-leading products in its.
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit — Neutral
NUTX PRNewsWire — September 29, 2025NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline.
3 Rare Earth Stocks That Could Keep Shining — Positive
METC MP USAR Schaeffers Research — September 29, 2025Wall Street has been closely monitoring rare earth stocks and their connection to the AI sector.
Citizens Financial Group Announces Third Quarter 2025 Earnings Conference Call Details — Neutral
CFG Business Wire — September 29, 2025PROVIDENCE, R.I.--(BUSINESS WIRE)--As previously announced, Citizens Financial Group, Inc. (NYSE: CFG) will report its third quarter 2025 earnings on October 15, 2025. The news release and supplemental materials will be available at http://investor.citizensbank.com. CFG management will host a live conference call that morning with details as follows: Time: 9:00 am (ET) Dial-in: To ask a question on the call, individuals may call in by dialing 800-369-1703, conference ID 3503262 For the listen o.
EA going private in $55 billion deal that will pay shareholders $210 a share — Positive
EA CNBC Television — September 29, 2025Electronic Arts said Monday that it has agreed to be acquired by the Public Investment Fund of Saudi Arabia, Silver Lake and Affinity Partners in an all-cash deal worth $55 billion. Shareholders of the company will receive $210 per share in cash.
SoFi Technologies (SOFI) experienced astounding stock growth over the last year. Now, Morgan Stanley warns its rally is overextended.
Critical Metals Corp Amends Agreement to Acquire a Controlling Interest in Tanbreez — Neutral
CRML GlobeNewsWire — September 29, 2025NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that it has amended its agreement to acquire the Tanbreez Greenland Rare Earth Mine (the “Tanbreez Project”) from Rimbal Pty Ltd. (“Rimbal”), a company controlled by geologist and project founder Gregory Barnes.
Qualcomm: The Market Is Proving Me Wrong (Upgrade) — Positive
QCOM Seeking Alpha — September 29, 2025Qualcomm stock has convincingly broken out of consolidation, with renewed momentum and optimism for its AI PC and automotive growth strategies. QCOM's Snapdragon X2 Elite series and automotive partnerships with Google and BMW underpin its diversification beyond mobile chipsets, supporting a bullish outlook. Despite Wall Street's caution due to modest near-term revenue growth, the market is regaining confidence in QCOM's AI-driven opportunities and competitive positioning.
NRC Authorizes NextEra Energy's Point Beach Nuclear Plant to Operate for Another 20 Years — Neutral
NEE PRNewsWire — September 29, 2025TWO RIVERS, Wis. , Sept. 29, 2025 /PRNewswire/ -- The U.S. Nuclear Regulatory Commission (NRC) has approved subsequent license renewal for Point Beach Nuclear Plant Units 1 and 2, extending operations through 2050 and 2053, respectively.
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit — Neutral
ALT PRNewsWire — September 29, 2025NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the "Class Period"), of the important October 6, 2025 lead plaintiff deadline.
Larimar Therapeutics, Inc. - Special Call Company Participants Carole Ben-Maimon - CEO, President & Director Conference Call Participants Alexandra Folias Yatin Suneja - Guggenheim Securities, LLC, Research Division Joori Park - Leerink Partners LLC, Research Division Samantha Semenkow - Citigroup Inc., Research Division Joon Lee - Truist Securities, Inc., Research Division Myles Minter - William Blair & Company L.L.C., Research Division Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division Cory Jubinville - LifeSci Capital, LLC, Research Division Presentation Operator Good morning, and welcome to the Larimar Therapeutics Conference Call.
Datavault AI Goes From Under the Radar to Fully Armed with Capital, Credibility, and Commitment — Neutral
DVLT Accesswire — September 29, 2025BEAVERTON, OR / ACCESS Newswire / September 29, 2025 / Datavault AI (NASDAQ: DVLT ) is no longer a quiet name drifting under the surface of the market. In the span of a week, the company has stacked a series of moves that turn it from a misunderstood microcap into one of the most compelling growth stories in AI.
'Teslaa Drives A Ford': Auto Giant's Clever Collab With Detroit Lions Rookie Wide Receiver — Positive
F Benzinga — September 29, 2025Detroit Lions rookie wide receiver Isaac Teslaa may not be one of the most recognizable NFL newcomers in 2025, but his one-handed highlight-reel catches are certainly helping. A collaboration with Ford Motor Co (NYSE: F) might help soon, too.
Enanta: Despite Primary Endpoint Miss Zelicapavir Could Benefit From Trial Design Change — Positive
ENTA Seeking Alpha — September 29, 2025Enanta Pharmaceuticals remains a Buy as zelicapavir shows multiple positive efficacy endpoints in RSV despite missing its primary endpoint in the phase 2b study. Zelicapavir demonstrated statistically significant improvements in PGI-S scores and viral load reduction, supporting potential for phase 3 advancement pending FDA feedback. Strong cash position funds operations into 2028, with ongoing MAVYRET/MAVIRET royalties and a manageable quarterly cash burn.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders — Neutral
CYBR STAA PRNewsWire — September 29, 2025NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: STAAR Surgical Company (NASDAQ: STAA)'s sale to Alcon for $28.00 per share in cash.
Comcast promotes Michael Cavanagh to co-CEO amid restructuring — Neutral
CMCSA Fast Company — September 29, 2025Comcast said on Monday it will appoint President Michael Cavanagh as co-CEO, adopting a dual chief executive model as the company prepares to spin off several NBCUniversal cable networks as part of a restructuring.
Uncertainty Supports Case for International Active ETFs — Neutral
TXUE TXUG ETF Trends — September 29, 2025The explosion of new active ETFs in the marketplace comes at a time when the investing environment has become more uncertain as 2025 comes to a close. Recent rate cuts, for example, could force investors to recalibrate their portfolios.
VANCOUVER, BC , Sept. 29, 2025 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) announces that it has completed the previously disclosed sale of its Juby Gold Project and related interests in Ontario, Canada, to McFarlane Lake Mining Limited (McFarlane) for total consideration of US$22 million, receiving US$13.2 million in cash and 82,023,746 common shares of McFarlane (representing 19.9% of McFarlane's post-financing share capital on a non-diluted basis, issued at C$0.15 per share).
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SMLR — Neutral
SMLR GlobeNewsWire — September 29, 2025NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.